A prospective cohort study on the efficacy and recurrence of FUAS in the treatment of uterine fibroids and adenomyopathy

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500097276

Enrollment

Unknown

Registered

2025-02-17

Start date

2025-03-01

Completion date

Unknown

Last updated

2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine fibroids and adenomyopathy

Interventions

observation group (focusedultrasound ablation surgery):None

control group (Traditional surgery to preserve the uterus):None

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age: >= 18 years old, <= 50 years old; diagnosed with uterine fibroids or adenomyosis by ultrasound or pelvic MRI; voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: Postmenopausal women; those with infection of important pelvic organs; those with severe internal medical conditions and unable to tolerate surgery or treatment; those who are severely allergic to MRI contrast agent, CT contrast agent or ultrasound contrast agent; those who are skeptical about the treatment plan.

Design outcomes

Primary

Measure	Time frame
Simplify Uterine Fibroid Symptom and Health-related Quality of Life questionnaire, sUFS-QOL;visual analogue scale, VAS;AM-SAS-10;	—

Countries

the People's Republic of China

Contacts

Public ContactLifen Liang

Foshan Maternal and Child Health Hospital

lfliang09@sina.com+86 180 3883 0574

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026